BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33450187)

  • 1. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.
    Wang E; Zhou H; Nadorp B; Cayanan G; Chen X; Yeaton AH; Nomikou S; Witkowski MT; Narang S; Kloetgen A; Thandapani P; Ravn-Boess N; Tsirigos A; Aifantis I
    Cell Stem Cell; 2021 Apr; 28(4):718-731.e6. PubMed ID: 33450187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting differentiation blockade in AML: New hope from cell-surface-based CRISPR screens.
    Su R; Qing Y; Chen J
    Cell Stem Cell; 2021 Apr; 28(4):585-587. PubMed ID: 33798415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
    Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
    Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
    De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
    Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia.
    Liu Q; Garcia M; Wang S; Chen CW
    Cells; 2020 Aug; 9(8):. PubMed ID: 32806592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells.
    Lee DH; Kang SH; Choi DS; Ko M; Choi E; Ahn H; Min H; Oh SJ; Lee MS; Park Y; Jin HS
    Cancer Lett; 2021 Jul; 510():37-47. PubMed ID: 33872695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exploration of novel therapeutic targets in acute myeloid leukemia via genome-wide CRISPR screening].
    Yamauchi T
    Rinsho Ketsueki; 2019; 60(7):810-817. PubMed ID: 31391371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies.
    Mercier FE; Shi J; Sykes DB; Oki T; Jankovic M; Man CH; Kfoury YS; Miller E; He S; Zhu A; Vasic R; Doench J; Orthwein A; Michor F; Scadden DT
    Blood Adv; 2022 Sep; 6(17):5072-5084. PubMed ID: 35793392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia.
    Bajaj J; Hamilton M; Shima Y; Chambers K; Spinler K; Van Nostrand EL; Yee BA; Blue SM; Chen M; Rizzeri D; Chuah C; Oehler VG; Broome HE; Sasik R; Scott-Browne J; Rao A; Yeo GW; Reya T
    Nat Cancer; 2020 Apr; 1(4):410-422. PubMed ID: 34109316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation.
    Liu J; Lu W; Liu S; Wang Y; Li S; Xu Y; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J
    Leuk Res; 2018 May; 68():15-21. PubMed ID: 29518627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of O-GlcNAcase Inhibits Hematopoietic and Leukemic Stem Cell Self-Renewal and Drives Dendritic Cell Differentiation via STAT3/5 Signaling.
    Luanpitpong S; Rodboon N; Samart P; Janan M; Klaihmon P; Lorthongpanich C; U-Pratya Y; Issaragrisil S
    Stem Cells; 2022 Dec; 40(12):1078-1093. PubMed ID: 36124999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
    Willman CL; Stewart CC; Longacre TL; Head DR; Habbersett R; Ziegler SF; Perlmutter RM
    Blood; 1991 Feb; 77(4):726-34. PubMed ID: 1825181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.
    Heyes E; Schmidt L; Manhart G; Eder T; Proietti L; Grebien F
    Leukemia; 2021 Sep; 35(9):2526-2538. PubMed ID: 33623142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E3 ligase SCF
    Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
    Life Sci; 2020 Sep; 257():118041. PubMed ID: 32622945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13.
    Prajapati SC; Dunham N; Fan H; Garrett-Bakelman FE
    Biotechniques; 2022 Mar; 72(3):81-84. PubMed ID: 35119307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors.
    Morris VA; Zhang A; Yang T; Stirewalt DL; Ramamurthy R; Meshinchi S; Oehler VG
    PLoS One; 2013; 8(9):e75815. PubMed ID: 24086639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling therapeutic targets in acute myeloid leukemia through multiplexed genome editing CRISPR screening.
    Tian Z; Octaviani S; Huang J
    Expert Opin Ther Targets; 2023; 27(12):1173-1176. PubMed ID: 38069633
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets.
    Wang T; Pine AR; Kotini AG; Yuan H; Zamparo L; Starczynowski DT; Leslie C; Papapetrou EP
    Cell Stem Cell; 2021 Jun; 28(6):1074-1089.e7. PubMed ID: 33571445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.